Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

There are six types of chronic myeloproliferative neoplasms, which vary based on whether the body is making too many red blood cells, white blood cells, or platelets. The bone marrow produces ...

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

About 20% of patients with myelofibrosis initially have no symptoms, allowing many cases to exist under the clinical suspicion of primary care clinicians. The need to treat asymptomatic or minimally ...

The study is evaluating AJ1-11095, a novel agent for the treatment of myelofibrosis that did not respond to or relapsed ...

host disease in patients with myelofibrosis and other myeloproliferative neoplasms. She also has an interest in improving patients’ return-to-work journey following stem cell transplant. To this end, ...